+
Another cosleeping/bedsharing* study came out today, and I expect to see this one getting lots of press, as it well should. It pulls together data from five previous studies, making it the largest study to date on this issue. It clearly lays out the risks for SIDS for babies who share a bed with parents, [...]
+
While a recent article by Angelina Jolie about her mastectomy and reconstruction raised awareness, it may have left the impression that the surgeries are quick and easy procedures, some doctors fear.
+
Although most attention is focused on the safety of infants and toddlers, their sudden jabs, bites, head-butts and kicks can inflict injuries on parents and other caregivers.
+
With pimples emerging well before the teenage years, and a rise in the number of preadolescent patients, doctors have put together guidelines on treatment for children as young as 7.
+
Bed rest is widely recommended in high-risk pregnancies. But there is little evidence to support it, and in some cases it may cause harm.
+
tumblr: bellapaige88On average, 9.5/1000 population has epilepsy in Low and Middle Income Countries (LAMIC). A research which has resulted in the global campaign against epilepsy has shown, the gap between treatment need and the treatment provision worldwide is approximately 70% [1]. This large ‘treatment gap’, i.e., lack of appropriate treatment for a large number of patients with epilepsy, due to a number of causes including inability to identify cases, inability to deliver adequate
[…]
Mbuba CK, Ngugi AK, Newton CR & Carter JA (2008). The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies., Epilepsia, 49 (9) 1491-503. PMID: 18557778
Pal, D., Das, T. & Sengupta, S. (2000). Case-control and qualitative study of attrition in a community epilepsy programme in rural India, Seizure, 9 (2) 119-123. DOI: 10.1053/seiz.1999.0357
Mani KS, Rangan G, Srinivas HV, Srindharan VS & Subbakrishna DK (2001). Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study., Lancet, 357 (9265) 1316-20. PMID: 11343735
+
Discrimination originates in prejudice. It most often takes the form of social rejection, with racial- and gender-based discrimination being two of the most common types. A curious phenomenon about the effects of discrimination is reported in the journal Psychological Science by the team of Wendy Mendes — a senior psychologist at the University of California, [...]
+
Lifeway Foods, Inc., supplier of kefir cultured dairy products, has announced the $7.4 million acquisition of the Golden Guernsey dairy plant in Waukesha, WI, to provide additional manufacturing capacity for its growing kefir-based business.
+
Lifeway Foods, Inc., has announced the $7.4 million acquisition of the Golden Guernsey dairy plant in Waukesha, WI, to provide additional manufacturing capacity for its growing kefir-based business.
+
This year's event provided activities focused on botanical identity and available testing methods and technologies, including an organoleptic tasting exercise, demonstrations from analytical labs and equipment providers, and discussions with legal and regulatory experts.
+
Second Botanical Congress provided activities focused on botanical identity and available testing methods and technologies, including an organoleptic tasting exercise, demonstrations from analytical labs and equipment providers, and discussions with legal and regulatory experts.
+
I had been debating whether to blog about Angelina Jolie’s announcement last week in a New York Times editorial entitled My Medical Choice that she had undergone bilateral prophylactic mastectomy because she had been discovered to have a mutation in the BRCA1 gene that is associated with a very high risk of breast cancer. On [...]
+
Simply focusing on sugar will do little to quell the rising epidemic in the United States.
+
Joel asks a variety of leading doctors, researchers and patient advocates for their reflections on the FDA Drug Development Workshop.
A short while ago, the US Food and Drug Administration (FDA) held a workshop for patients, doctors, and other stakeholders, to talk about drug development for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). You can read a summary of the first and second parts of day one of the two-day workshop, here and here. (Day two summaries will be published
[…]
